BFC Planning’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$61.2K Sell
1,511
-204,498
-99% -$9.9M ﹤0.01% 1455
2026
Q2
$10.8M Buy
206,009
+204,459
+13,191% +$7.98M 0.44% 45
2026
Q1
$54.8K Sell
1,550
-68
-4% -$2.11K ﹤0.01% 1300
2025
Q4
$45.3K Buy
1,618
+1,061
+190% +$31.8K ﹤0.01% 1409
2025
Q3
$16.7K Hold
557
– – ﹤0.01% 1670
2025
Q2
$15.9K Sell
557
-20
-3% -$595 ﹤0.01% 1599
2025
Q1
$19.1K Buy
577
+27
+5% +$881 ﹤0.01% 1482
2024
Q4
$15.8K Sell
550
-14
-2% -$402 ﹤0.01% 1555
2024
Q3
$15.8K Buy
+564
New +$15K ﹤0.01% 1551

Other funds holding ALKS

BFC Planning's ALKS Position: Q3 2026 in Review

BFC Planning reduced its Alkermes (ALKS) stake by 99% in Q3 2026, selling an estimated $9.9M and leaving 1,511 shares worth $61.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1455.

BFC Planning first reported a position in ALKS in Q3 2024 and has held it in 9 quarters since. The position peaked at $10.8M in Q2 2026. 312 funds tracked by Wall St. Rank hold ALKS as of Q3 2026.

  • BFC Planning held 1,511 shares of Alkermes worth $61.2K as of Q3 2026.
  • BFC Planning sold 204,498 Alkermes shares in Q3 2026, an estimated $9.9M.
  • Alkermes made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #1455 holding.
  • BFC Planning first reported a position in Alkermes in Q3 2024 and has held it in 9 quarters since.
  • BFC Planning's Alkermes position peaked at $10.8M in Q2 2026.
  • 312 funds tracked by Wall St. Rank held Alkermes as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.